SCHEMBL2470530

SCHEMBL2470530

CN(C)CC=Nc1nc(Br)cnc1N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.41
CKS1B P61024 2/20 0.40
SKP1 P63208 2/20 0.40
SKP2 Q13309 2/20 0.40
TLR9 Q9NR96 2/20 0.39
GPR119 Q8TDV5 9/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
PTPN11 Q06124 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
GBA1 P04062 1/20 0.37
ACHE P22303 1/20 0.37
KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12269591 0.87 CKS1B (0.41) MAP4K4CKS1BSKP1SKP2TLR9
SCHEMBL2465903 0.86 PTPN11 (0.42) MAP4K4CKS1BSKP1SKP2GPR119
SCHEMBL2468758 0.86 P2RY12 (0.31)
SCHEMBL12269550 0.83 CKS1B (0.41) MAP4K4CKS1BSKP1SKP2TLR9
SCHEMBL2401989 0.81 NR1H2 (0.42) MAP4K4CKS1BSKP1SKP2TLR9
SCHEMBL2401992 0.81 NR1H2 (0.42) MAP4K4CKS1BSKP1SKP2TLR9
SCHEMBL2401136 0.78 CKS1B (0.42) MAP4K4CKS1BSKP1SKP2TLR9
SCHEMBL2401143 0.78 CKS1B (0.42) MAP4K4CKS1BSKP1SKP2TLR9
SCHEMBL12269558 0.78 CKS1B (0.42) MAP4K4CKS1BSKP1SKP2TLR9
SCHEMBL2402337 0.77 MAP4K4 (0.52) MAP4K4CKS1BSKP1SKP2TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545058-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE Kalypsys, Inc. (US) 2013-01-16 EP disclosed
WO-2011112766-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2011-09-15 WO disclosed